In a phase 2 trial of 56 adults with SLE and objective neuropsychological dysfunction, 12 weeks of memantine vs placebo gave a greater median RBANS total score gain (+8 vs +5; P=.032; 43 analysed). Self-reported improvement did not differ significantly (61% vs 36%).
RCTn = 56
Rhoads et al. Improvement in neuropsychological function with memantine treatment among patients with systemic lupus erythematosus: a phase 2 randomised placebo-controlled clinical trial